Overview

Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of golimumab in Chinese patients with rheumatoid arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Collaborator:
Schering-Plough
Treatments:
Antibodies, Monoclonal
Golimumab
Methotrexate